Klein Lawrence Otto
- SEC CIK
- 0001762583
In the past year, 4 open-market sale filings worth $7.31M and no purchases.
Current role at each company
- ORKA Oruka Therapeutics, Inc.Chief Executive Officeras of Sep 15, 2026
- JBIO Jade Biosciences, Inc.Directoras of Jun 11, 2026
- JSPR Jasper Therapeutics, Inc.Directoras of Jun 8, 2023
- CRSP CRISPR Therapeutics AGCBO & COOas of Aug 18, 2022
- DYN Dyne Therapeutics, Inc.Directoras of Jul 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.31M
- 4 filings
- Net
- −$7.31M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Klein Lawrence Otto as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ORKA Oruka Therapeutics, Inc.
Chief Executive Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)7:15 PM ET | Sep 15 | Same day | Klein Lawrence OttoChief Executive Officer | SSale | −2.45K | $95.71 | −$234.7K | −0.3%923.1K after | |
| Sep 1, 2026 (view filing)6:35 PM ET | Sep 1 | Same day | Klein Lawrence OttoChief Executive Officer | SSale | −75.0K | $91.83 | −$6.89M | −7.5%925.6K after | 3 lots10b5-1 |
| Jun 15, 2026 (view filing) | Jun 15 | Same day | Klein Lawrence OttoChief Executive Officer | SSale | −1.73K | $69.69 | −$120.5K | −0.2%925.6K after | |
| Mar 17, 2026 (view filing) | Mar 16 | 1 day | Klein Lawrence OttoChief Executive Officer | SSale | −1.73K | $41.30 | −$71.4K | −0.2%927.3K after |